Chinese researchers have unearthed a powerful vulnerability buried deep inside one of the deadliest forms of cancer. At the heart of liver cancer’s survival lies a fuel-sharing system powered by lactate, a metabolic byproduct once dismissed as cellular waste. It turns out these tumors are anything but wasteful. They thrive on lactate, pumping it across cells using a specialized protein called MCT1. That protein has now become a bullseye.
A research team led by Professor Ye Sheng at Tianjin University has not only mapped how MCT1 works but also discovered how to shut it down. Their weapon of choice is silybin, a compound pulled from traditional Chinese medicine, long known for its antioxidant and liver-protecting properties. This time, it’s doing something far more aggressive.
Silybin doesn’t just slow cancer. It jams the cancer’s metabolic gears. It binds precisely to MCT1 and blocks its transport channel, trapping lactate inside the cancer cells. This results in a metabolic gridlock that starves tumors of energy while poisoning them with their own acidic waste.
🇨🇳CHINESE SCIENTISTS FIND CANCER'S HIDDEN FUEL LINE
Liver cancer cells thrive on lactate – an energy source they pump and share through a protein called MCT1.
A team led by Professor Ye Sheng at Tianjin University cracked the code behind MCT1’s transport mechanism – and found a… https://t.co/gdkvC9mtS1 pic.twitter.com/wz9WtIJUjW
— Mario Nawfal (@MarioNawfal) April 6, 2025
Traditional treatments like chemotherapy and radiation are non-selective, damaging both cancerous and healthy cells, often leading to severe side effects. Targeting MCT1 with silybin offers a highly selective approach by cutting off the lactate-fueled metabolic pathway unique to…
— Dr. Simon Hundeshagen (@shundeshagen) April 6, 2025